IP Library Granted Patent US 7,700,301
Granted Patent B2
US 7,700,301 · App. 11/519,186 · Granted Apr 20, 2010

Methods for screening for compounds that modulate PD-1 signaling

Assignees: Dana-Farber Cancer Institute Inc.; Wyeth
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,301
App. No.
11/519,186
Granted
Apr 20, 2010
Kind
B2
Abstract

Disclosed are screening assays for identifying compounds which modulate the activity of, or signaling via, B7-4, or PD-1, especially which modulate the binding of B7-4 or PD-1 to a target molecule.

Claims (7)

1. A method for screening for compounds which modulate PD-1 signaling comprising:

a) contacting a T cell activated in the presence of PD-L1 with a test compound;

b) contacting a T cell activated in the absence of PD-L1 with the test compound; and

c) determining the ability of the test compound to modulate phosphorylation of SHP-2;

wherein modulation of phosphorylation of SHP-2 in the presence of PD-L1 and not in the absence of PD-L1 indicates modulation of PD-1 signaling, thereby identifying a compound which modulates PD-1 signaling.

2. The method of claim 1 wherein the test compound upmodulates PD-1 signaling and thereby upmodulates SHP-2 phosphorylation.

3. The method of claim 1 wherein the test compound downmodulates PD-1 signaling and thereby downmodulates SHP-2 phosphorylation.

Assignments (1)
CONFIRMATORY LICENSE Recorded Mar 17, 2015
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035214/0261 →
Continuity (3)
Division 1011561500 · Apr 2, 2002
Provisional Application 6028106400 · Apr 2, 2001
Related Publication 20080274490A1 · Nov 6, 2008